Quick Answer
MAIA Biotechnology, Inc. reported Total Assets of $9.70 million for the year ending 2025.
- MAIA Biotechnology, Inc. showed a decrease of -4.4% in Total Assets from 2024 to 2025.
- This data is from MAIA Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $9.76 million | Q3 2022: $14.78 million | Q1 2023: $9.07 million | Q2 2023: $10.27 million | Q3 2023: $7.00 million | Q1 2024: $8.72 million | Q2 2024: $12.02 million | Q3 2024: $9.24 million | Q1 2025: $11.86 million | Q2 2025: $11.05 million | Q3 2025: $11.78 million.
- Over the full 5 years of available data (2021 to 2025), MAIA Biotechnology, Inc.'s Total Assets has declined by 14.3%.
- Historical annual values: Fiscal year 2025: $9.70 million | Fiscal year 2024: $10.16 million | Fiscal year 2023: $7.57 million | Fiscal year 2022: $12.02 million | Fiscal year 2021: $11.33 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: